Benzinga·2025-11-21 18:51Group 1: FuboTV and Rocket Companies - FuboTV reported a 2.3% year-over-year decline in revenue for Q3 2025, totaling $377.20 million, which exceeded the analyst consensus estimate of $361.33 million [1] - Rocket Companies reported quarterly earnings of 7 cents per share, surpassing the Street estimate of 5 cents, with quarterly revenue of $1.78 billion, beating the consensus estimate of $1.66 billion [1] Group 2: Regeneron Pharmaceuticals - The U.S. FDA approved Regeneron Pharmaceuticals' Eylea HD Injection 8 mg for patients with macular edema following retinal vein occlusion, allowing for dosing every 8 weeks after an initial monthly period [2] - Regeneron Pharmaceuticals shares increased by 5% to close at $737.00 [5] Group 3: Stock Price Movements - Rocket Companies shares decreased by 3.6% to settle at $16.17 [5] - Netflix shares fell by 3.9% to close at $105.67 [5] - FuboTV shares dropped by 5% to close at $3.24 [5]